Anti-Hypertensive Flashcards
First line drugs of choice
Diuretics Calcium Channel Blockers ACE inhibitors Angiotensin Receptor Blockers (BB are not first line because they do not work well in AA populations, and cause significant side effects
Diuretics
Drugs of choice in uncomplicated hypertension
Mild/moderate hypertension with lifestyle modification
Thiazides
Hydrochlorothiazide, Chlorthalidone Inhibits Na/Cl cotransporter Initial volume contraction Decreased peripheral resistance (prostaglandins) Mild Na excretory effects
Loop Diuretics
Furosemide (Lasix)
Blocks Na/K/2Cl co-transporter in TAL
Venous dilation from prostaglandins
Dehydration/hyponatremia, hypokalemia, impaired diabetes control, increased LDL/HDL, ototoxicity
Drug interactions: NSAIDs, Aminoglycosides
K Sparing Diuretics
Spironolactone, eplerenone, tramterene, amiloride
Aldosterone receptor blocker/prevent insertion of ENAC channels in collecting tubule
Side Effects: Hyperkalemia, gynecomastia (spironolactone)
Drug interactions: NSAIDs (block good effects of prostaglandins), ACE inhibitors and ARBs (also inhibit aldosterone)
Contraindications: RAS inhibitors (have both ACE inhibitors and ARBs)
Ca Channel Blockers
Nondihydropyridine
Can do heart and smooth muscle receptors
Ca Channel Blockeres
Dihydropyridines
More selective for vascular smooth muscle
Ca Channel Blockers
MoA: Reduce vascular resistance by reducing Ca influx
Non-dihydropyridine reduce pacemaker potentials, AV node conduction, and contractility
Ca Channel Blockers
Nifedipine
Dihydropyridine
Limited affect on pacemaker or conduction
SE: acute tachycardia, headache, peripheral edema (arteriolar dilation > venodilation), flushing
Ca Channel Blockers
Diltiazem
Non-dyhydropyridine
Reduces pacemaker and conduction current
SE: dizziness, headache, edema, bradycardia
Ca Channel Blockers
Verapamil
Non-dihydropyridine
More pronounced reduction of current
SE: dizziness, headache, edema, constipation, bradycardia
CCB therapeutic Notes
Non-dihydropyridines are contraindicated in patients with conduction disturbances
Use non-dihydropyridine with caution in patient given B-blockers
Avoid use of short acting CCBs for chronic hypertension
Sympatholytic Drugs
MOA: Reduces sympathetic-mediated vasoconstriction, Co, and renin release
Clonidine
Sympatholytic Drug
Centrally acting agent
a2 adrenergic receptor agonist in medullary CV center
Decreases sympathetic outflow from CNS
SE: sedation, dry mouth, bradycardia, dermatitis
Drug interactions: CNS depressants
Withdraw slowly to prevent rebound hypertension
Guanfacine
Longer half-life than clonidine
Less chance of rebound hypertension
Methyldopa
Sympatholytic Drug
a2-adrenergic receptor agonist (same MOA as clonidine)
Competes wtih L-DOPA for DOPA decarboxylase
Inhibits dopamine production
Drug interactions: levodopa
SE: Sedation, nightmares, movement disorders, hyperprolactinemia, anemia
Contraindications: Liver Dx
USED IN HYPERTENSION WITH PREGGOS
Reserpine
Indirect Acting Adrenergic Blocking Agent
Blocks VMAT vesicular transporter
Prevents storage of NE centerally and peripherally
Combined with diuretics for mild/moderate HTN
SE: sedation, diarrhea, depression, bradycardia, nasal congestion
Drug interactions: CNS depressant, MAOIs
Alpha Adrenergic Receptor Antagonists
Block a-adrenergic-mediated vasoconstriction at receptor
Phenoxybenzamine
Alpha adrenergic receptor antagonist
Non selective
Primary use in PHEOCHROMOCYTOMA
SE: Tachycardia
Prazosin
Alpha adrenergic receptor antagonist
Less tachycardia than direct vasodilators
Initial hypotension
Does not impair exercise tolerance
Terazosin and doxazosin have longer half-life
SE: Hypotension (first dose), dizziness, headaches, weakness
Also decreases LDL/HDL
Beta Blockers
Decrease cardiac contractility and CO
Decrease renin secretion
Decrease angiotensin II production
Propranolol
Nonselective B-blocker
Mild/moderate hypertension
Adjunct to prevent tachycardia with vasodilators
Lipophilic